LIMITX™ Technology
LIMITX™ Technology is intended to mitigate the risks associated with intentional or accidental overdose.
LTX-03, an immediate-release hydrocodone bitartrate with acetaminophen tablet, is our lead LIMITX™ development program. Previously, we have run three exploratory human pharmacokinetic studies and two animal studies.